122 related articles for article (PubMed ID: 28445053)
1. Sulfotransferases and Breast Cancer Resistance Protein Determine the Disposition of Calycosin in Vitro and in Vivo.
Yu J; Zhu L; Zheng H; Gong X; Jiang H; Chen J; Li Y; Zheng H; Qi X; Wang Y; Hu M; Lu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2917-2929. PubMed ID: 28445053
[TBL] [Abstract][Full Text] [Related]
2. Sulfonation Disposition of Acacetin: In Vitro and in Vivo.
Zhang Q; Zhu L; Gong X; Ruan Y; Yu J; Jiang H; Wang Y; Qi X; Lu L; Liu Z
J Agric Food Chem; 2017 Jun; 65(24):4921-4931. PubMed ID: 28540728
[TBL] [Abstract][Full Text] [Related]
3. Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein.
Liu H; Huang L; Li Y; Fu T; Sun X; Zhang YY; Gao R; Chen Q; Zhang W; Sahi J; Summerfield S; Dong K
Drug Metab Dispos; 2017 May; 45(5):449-456. PubMed ID: 28209803
[TBL] [Abstract][Full Text] [Related]
4. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
An G; Gallegos J; Morris ME
Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine.
Zhu W; Xu H; Wang SW; Hu M
AAPS J; 2010 Dec; 12(4):525-36. PubMed ID: 20582579
[TBL] [Abstract][Full Text] [Related]
6. The sulfated conjugate of biochanin A is a substrate of breast cancer resistant protein (ABCG2).
An G; Morris ME
Biopharm Drug Dispos; 2011 Nov; 32(8):446-57. PubMed ID: 21910126
[TBL] [Abstract][Full Text] [Related]
7. Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites.
Zhou X; Wang S; Sun H; Wu B
Drug Metab Pharmacokinet; 2015 Dec; 30(6):425-33. PubMed ID: 26611713
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates With Estrone-3-Sulfate Transport in Caco-2.
Harwood MD; Neuhoff S; Rostami-Hodjegan A; Warhurst G
J Pharm Sci; 2016 Apr; 105(4):1370-5. PubMed ID: 26952881
[TBL] [Abstract][Full Text] [Related]
9. Regional expression and activity of breast cancer resistance protein (Bcrp/Abcg2) in mouse intestine: overlapping distribution with sulfotransferases.
Enokizono J; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Jun; 35(6):922-8. PubMed ID: 17353350
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
González-Sarrías A; Miguel V; Merino G; Lucas R; Morales JC; Tomás-Barberán F; Alvarez AI; Espín JC
J Agric Food Chem; 2013 May; 61(18):4352-9. PubMed ID: 23586460
[TBL] [Abstract][Full Text] [Related]
11. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.
Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152
[TBL] [Abstract][Full Text] [Related]
12. Sulfation disposition of liquiritigenin in SULT1A3 overexpressing HEK293 cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 4 (MRP4) in sulfate efflux of liquiritigenin.
Liu T; Zhang X; Zhang Y; Hou J; Fang D; Sun H; Li Q; Xie S
Eur J Pharm Sci; 2018 Nov; 124():228-239. PubMed ID: 30176366
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.
Jiang H; Yu J; Zheng H; Chen J; Wu J; Qi X; Wang Y; Wang X; Hu M; Zhu L; Liu Z
Pharm Res; 2017 Jul; 34(7):1402-1415. PubMed ID: 28421306
[TBL] [Abstract][Full Text] [Related]
14. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
[TBL] [Abstract][Full Text] [Related]
15. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
Shen H; Lee FY; Gan J
J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
[TBL] [Abstract][Full Text] [Related]
16. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
17. Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.
Ge S; Yin T; Xu B; Gao S; Hu M
Pharm Res; 2016 Mar; 33(3):590-602. PubMed ID: 26502886
[TBL] [Abstract][Full Text] [Related]
18. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
Mukkavilli R; Jadhav G; Vangala S
Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
